Updates are available Correction dated 2020-09-16
Click to view Correction: https://doi.org/10.1038/s41556-020-00589-3
-
Authors
Martínez-Zamudio, Ricardo Iván https://orcid.org/0000-0001-9202-4285
Roux, Pierre-François
de Freitas, José Américo N.L.F. https://orcid.org/0000-0003-3689-765X
Robinson, Lucas
Doré, Gregory
Sun, Bin https://orcid.org/0000-0002-8963-4100
Belenki, Dimitri https://orcid.org/0000-0002-9004-9849
Milanovic, Maja https://orcid.org/0000-0003-1860-6003
Herbig, Utz
Schmitt, Clemens A. https://orcid.org/0000-0002-4731-2226
Gil, Jesús https://orcid.org/0000-0002-4303-6260
Bischof, Oliver https://orcid.org/0000-0003-2422-6277
- License Information
-
More Information
Article History
Received: 7 June 2019
Accepted: 27 April 2020
First Online: 8 June 2020
Change Date: 16 September 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41556-020-00589-3
Competing interests
: J.G. owns equity and has acted as a consultant for Unity Biotechnology and Geras Bio. Unity Biotechnology funded research on senolytics in J.G.’s laboratory. J.G. is a named inventor in an MRC patent related to senolytic therapies (PCT/GB2018/051437). All of these links are not directly related to the results presented in this paper.
